Gene: BTBD9
Official Full Name: BTB domain containing 9provided by HGNC
Gene Summary: This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00617 | BTBD9 gRNA1-gRNA2 KO plasmid | BTBD9 | $850 | |||
KO00755 | BTBD9 Knockout cell line (SH-SY5Y) | Human | BTBD9 | 1:2-1:3 | Negative | Online Inquiry |
KO19350 | BTBD9 Knockout cell line (HeLa) | Human | BTBD9 | 1:3~1:6 | Negative | Online Inquiry |
KO19351 | BTBD9 Knockout cell line (HCT 116) | Human | BTBD9 | 1:2~1:4 | Negative | Online Inquiry |
KO19352 | BTBD9 Knockout cell line (HEK293) | Human | BTBD9 | 1:3~1:6 | Negative | Online Inquiry |
KO19353 | BTBD9 Knockout cell line (A549) | Human | BTBD9 | 1:3~1:4 | Negative | Online Inquiry |
BTBD9 Gene Knockout Cell Lines are meticulously engineered cellular models targeting the BTBD9 gene, known for its role in various biological and disease processes, including neurodegenerative disorders and certain genetic predispositions. These cell lines allow researchers to eliminate the expression of BTBD9, leading to the examination of its function and implications in health and disease.
The key function of the BTBD9 Gene Knockout Cell Lines involves the deletion of BTBD9, facilitating detailed analysis of the gene's contribution to cellular pathways and disease mechanisms. The knockout cells provide an invaluable tool for investigating molecular signaling, gene expression patterns, and phenotypic variations associated with BTBD9 disruption. By offering a controlled environment to study the absence of this gene, researchers can explore the cellular responses and compensatory mechanisms that arise, enhancing the understanding of BTBD9's role.
Scientifically, these knockout cell lines are pivotal in research settings, particularly in elucidating the molecular underpinnings of conditions like movement disorders and psychiatric illnesses. Their applications extend to drug discovery, genetic function studies, and development of targeted therapies, making them a critical asset for academic and pharmaceutical research.
Compared to traditional methods, such as knockdown or pharmacological inhibition, BTBD9 Gene Knockout Cell Lines provide a permanent genetic alteration, allowing for long-term studies and more definitive results. This permanence eliminates variability associated with transient methods and creates a reproducible framework for experiments.
For researchers and clinicians, the ability to use these established models translates into significant time savings and increased reliability in experimental outcomes. This ease of use, coupled with the consistency of results, makes the BTBD9 Gene Knockout Cell Lines an essential addition to any investigatory toolkit.
Our company specializes in providing high-quality biological products designed with precision and reliability to support cutting-edge research. With a commitment to excellence and innovation, we empower scientists and clinicians to explore new frontiers in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.